- Home
- DNTH vs BELFB Comparison
DNTH vs BELFB Comparison
Compare DNTH & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | BELFB |
|---|---|---|
| Founded | 2015 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DNTH | BELFB |
|---|---|---|
| Price | $44.24 | $166.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $68.00 | ★ $153.75 |
| AVG Volume (30 Days) | ★ 765.4K | 166.7K |
| Earning Date | 11-05-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | N/A | ★ 19.52 |
| EPS | N/A | ★ 5.17 |
| Revenue | $3,078,000.00 | ★ $649,376,000.00 |
| Revenue This Year | N/A | $28.52 |
| Revenue Next Year | N/A | $6.49 |
| P/E Ratio | ★ N/A | $32.12 |
| Revenue Growth | N/A | ★ 23.70 |
| 52 Week Low | $13.37 | $58.00 |
| 52 Week High | $45.46 | $167.04 |
Technical Indicators
Market Signals| Indicator | DNTH | BELFB |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 63.36 |
| Support Level | $42.00 | $133.71 |
| Resistance Level | $45.46 | $159.47 |
| Average True Range (ATR) | 2.00 | 8.21 |
| MACD | 0.13 | 1.92 |
| Stochastic Oscillator | 79.49 | 98.06 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.